Orange Book product · Generic (ANDA)
NADOLOL
NADOLOL
At a glance
Aug 30, 1996
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 30, 1996
30 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
NADOLOL
Strength
20MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 074229
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NADOLOL
- 1986CORGARDBrand (NDA)
NDA 018063 · USWM
- 2023NADOLOLGeneric (ANDA)
ANDA 211763 · ALEMBIC
- 2022NADOLOLGeneric (ANDA)
ANDA 201893 · AUROBINDO PHARMA
- 2019NADOLOLGeneric (ANDA)
ANDA 212856 · RK PHARMA
- 2018NADOLOLGeneric (ANDA)
ANDA 210955 · REGCON HOLDINGS
- 2018NADOLOLGeneric (ANDA)
ANDA 210786 · INGENUS PHARMS LLC
- 2017NADOLOLGeneric (ANDA)
ANDA 209309 · CHARTWELL RX
- 2017NADOLOLGeneric (ANDA)
ANDA 207761 · ZYDUS PHARMS
- 2017NADOLOLGeneric (ANDA)
ANDA 208832 · AMNEAL PHARMS CO
- 2015NADOLOLGeneric (ANDA)
ANDA 203455 · INVAGEN PHARMS
- 1996NADOLOLGeneric (ANDA)
ANDA 074255 · HERITAGE PHARMA
- 1995NADOLOLGeneric (ANDA)
ANDA 074501 · SANDOZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
